Abstract: . . .  with antioxidants. Arzneimittel- forschung 1992;42:297-302. 85. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, dou- ble-blind, placebo-controlled study of supplemental vitamin E on attenua- tion of the development of nitrate tolerance. Circulation 1997;96:2545- 50. 86. Rajagopalan S, Kurz S, Mnzel T, et al. Angiotensin II-mediated hy- pertension in the rat increases vascular superoxide production via mem- brane NADH/NADPH oxidase activation: . . .
. . .  Hydralazine prevents nitroglyc- erin tolerance by inhibiting activation of a membrane-bound NADH oxi- dase: a new action for an old drug. J Clin Invest 1996;98:1465-70. 88. Cohn JN, Archibald DG, Zeische S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Ad- ministration Cooperative Study . . .
. . .  alterations of vasomotor tone. J Clin Invest 1996;97:1916-23. 87. Mnzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglyc- erin tolerance by inhibiting activation of a membrane-bound NADH oxi- dase: a new action for an old drug. J Clin Invest 1996;98:1465-70. 88. Cohn JN, Archibald DG, Zeische S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Ad- ministration Cooperative Study . . .
. . .  tolerance with diuretics. Am Heart J 1995;130:522-7. 83. Parker JD, Parker AB, Farrell B, Parker JO. The effects of diuretic ther- apy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina . Circulation 1996;93:691-6. 84. Yeates RA, Schmid M. Total prevention of the development of in vitro tolerance to organic nitrates: experiments with antioxidants. Arzneimittel- forschung 1992;42:297-302. 85. Watanabe . . .
. . .  tolerance with diuretics. Am Heart J 1995;130:522-7. 83. Parker JD, Parker AB, Farrell B, Parker JO. The effects of diuretic ther- apy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina . Circulation 1996;93:691-6. 84. Yeates RA, Schmid M. Total prevention of the development of in vitro tolerance to organic nitrates: experiments with antioxidants. Arzneimittel- forschung 1992;42:297-302. 85. Watanabe H, . . .
. . .  angiotension converting enzyme inhibitors. Circulation 1991; 83:1271-7. 78. Muiesan ML, Boni E, Castellano M, et al. Effects of transdermal ni- troglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris . Eur Heart J 1993;14:1701-8. 79. Mnzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evi- dence for enhanced vascular superoxide anion production in nitrate toler- ance: a novel mechanism underlying tolerance and cross-tolerance. . . .
--3000,6,250,3331,64460